Larvol Delta - Chronic-Spontaneous-Urticaria-in-Finland--A-Nationwide-Registry-Study-on-Epidemiology-and-Treatment-Patterns-in-Secondary-Care

Xolair (omalizumab) - Roche, Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42770913

Emma Heikkinen; Jari Jokelainen; Laura Huilaja; Maija Wolf; Stina Roth; Suvi-Päivikki Sinikumpu

Sep 23, 2026